A group of seven US healthcare organisations representing around 500 hospitals has realised plans to form a non-profit generics company, as a means to tackle shortages and address rising drug costs, officially establishing itself as Civica Rx and naming former Amgen executive Martin VanTrieste as its chief executive officer.
A group of seven US healthcare organisations representing around 500 hospitals has realised plans to form a non-profit generics company, as a means to tackle shortages and address rising drug costs, officially establishing itself as Civica Rx and naming former Amgen executive Martin VanTrieste as its chief executive officer.
The number of representatives has risen since it was announced in January this year (Generics bulletin, 26 January 2018, page...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
